Epidemiological studies suggest that HSV-2 increases the risk of HIV-1 acquisition. 1, 2, 3 In populations with HSV-2 prevalence of 80%, nearly 50% of HIV-1 infections are attributable to an HSV-2 ...
WOBURN, Mass. and OXFORD, England, July 8, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced ...
Herpes simplex virus 2 (HSV-2) is a sexually transmitted infection that can cause painful, recurrent lesions in the genital skin and mucosa. HSV-2 initially infects genital epithelial cells before ...
System from Quest Diagnostics’ products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection Quest Diagnostics (NYSE: ...
Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...
Asymptomatic herpes simplex virus type 2 (HSV-2) infection is well described, but its natural history and relative transmissibility remain unclear. In this prospective study, researchers evaluated the ...
In this study, anti-HSV-2 activities of GA were evaluated both in cell culture and in a genital model of mice infected with HSV-2. Female Kunming mice (5–6 weeks in age and 13–15 g in weight) were ...
Epidemiologic data suggest that infection with herpes simplex virus type 2 (HSV-2) is associated with increased genital shedding of human immunodeficiency virus type 1 (HIV-1) RNA and HIV-1 ...
Although condoms probably can prevent herpes simplex virus type 2 (HSV-2) infection, research data on the issue are sparse. To learn more, researchers studied 1843 men and women who were participants ...
As per the data released by the World Health Organisation (WHO), 3.7 billion people globally have herpes simplex virus type 1 (HSV 1) and 491 million have herpes simplex virus type 2 (HSV-2) infection ...
Assembly Biosciences Inc. has selected development candidate ABI-5366 to progress to IND-enabling studies from its long-acting herpes simplex virus type 2 (HSV-2) helicase inhibitor program for ...
Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls No significant financial relationships to disclose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results